In NAGS-deficiency, oral carbamylglutamate (carglumic acid) can be given to activate CPS1, which results in increased protein tolerance (Singh et al. 2024). This evidence concerns the gene CPS1 and hyperinsulinemic hypoglycemia, familial, 4.